Accession Therapeutics
Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.
Accession Therapeutics is a tech company based in Oxford, United Kingdom, started in 2020. Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.
- Website
- accessiontherapeutics.com
- City
- Oxford
- Country
- United Kingdom
- Founded
- 2020
- AI-native
- No
- Registered
- Company 13083685
- Office
- OX4, Oxford
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in Oxford
Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
FinalDose
Programmable DNA drug destroying all cancers, unlocking 80% of targets
Evolvere BioSciences
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Blue Earth Therapeutics
Advancing next generation targeted radiopharmaceuticals to treat patients who have cancer.
Canos
AI-powered blood test to detect cancer in dogs (and cats soon).
Gordian Pharma
Claim this profile
Free and instant: prove you run accessiontherapeutics.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Accession Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Accession Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
